Therapeutics Hormonal Agents

Anti-inflammatory effects of progesterone in lipopolysaccharide-stimulated BV-2 microglia

Lei B, Mace B, Dawson HN, Warner DS, Laskowitz DT, James ML

Published July 31, 2014 PLoS One
DOI 10.1371/journal.pone.0103969 PMID 25080336 PMC PMC4117574

RRM Academy Synopsis

Progesterone lowers inflammatory signals in lab-grown mouse microglia

A lab study of mouse brain immune cells found that progesterone, added before an inflammatory trigger, lowered inflammation markers in the cells. The progesterone receptor blocker mifepristone reversed the effect in the cells. Progesterone added after the trigger changed none of the markers tested.

Key Findings

  • Progesterone given 1 hour before the trigger lowered TNF-α, iNOS and COX-2 levels, and larger amounts lowered them further.
  • The two higher progesterone concentrations lowered soluble TNF-α by approximately 20% (n = 7).
  • Progesterone pretreatment reduced IκBα and p65 phosphorylation and p65 movement into the nucleus, markers of NF-κB activation. It also lowered p38, JNK and ERK phosphorylation (n = 3).
  • The receptor blocker mifepristone reversed these effects on the inflammatory proteins and on both signaling pathways.
  • Progesterone given 5, 30 or 60 minutes after the trigger left the NF-κB markers, iNOS, COX-2 and p38 phosphorylation unchanged (n = 3).

Interpretation

The authors used BV-2 cells, a mouse cell line grown in a dish, with three to seven repeat experiments per comparison. Progesterone changed inflammatory signaling when present before the trigger. The authors propose that progesterone may serve as a neuroprotective agent against acute brain inflammation, in line with earlier animal injury models. They note that primary microglia differ from BV-2 cells, and that confirming the results in primary adult microglia would strengthen that proposal.

RRM Context

The introduction describes progesterone acting in the brain through nuclear and membrane receptors, with roles in memory, cognition and neurogenesis. This work adds an anti-inflammatory action in microglia that depends on the receptor. Progesterone signals well beyond the ovary and uterus, which fits RRM's view of the menstrual cycle as a whole-body vital sign.

Abstract

Female sex is associated with improved outcome in experimental brain injury models, such as traumatic brain injury, ischemic stroke, and intracerebral hemorrhage. This implies female gonadal steroids may be neuroprotective. A mechanism for this may involve modulation of post-injury neuroinflammation. As the resident immunomodulatory cells in central nervous system, microglia are activated during acute brain injury and produce inflammatory mediators which contribute to secondary injury including proinflammatory cytokines, and nitric oxide (NO) and prostaglandin E2 (PGE2), mediated by inducible NO synthase (iNOS) and cyclooxygenase-2 (COX-2), respectively. We hypothesized that female gonadal steroids reduce microglia mediated neuroinflammation. In this study, the progesterone's effects on tumor necrosis factor alpha (TNF-α), iNOS, and COX-2 expression were investigated in lipopolysaccharide (LPS)-stimulated BV-2 microglia. Further, investigation included nuclear factor kappa B (NF-κB) and mitogen activated protein kinase (MAPK) pathways. LPS (30 ng/ml) upregulated TNF-α, iNOS, and COX-2 protein expression in BV-2 cells. Progesterone pretreatment attenuated LPS-stimulated TNF-α, iNOS, and COX-2 expression in a dose-dependent fashion. Progesterone suppressed LPS-induced NF-κB activation by decreasing inhibitory κBα and NF-κB p65 phosphorylation and p65 nuclear translocation. Progesterone decreased LPS-mediated phosphorylation of p38, c-Jun N-terminal kinase and extracellular regulated kinase MAPKs. These progesterone effects were inhibited by its antagonist mifepristone. In conclusion, progesterone exhibits pleiotropic anti-inflammatory effects in LPS-stimulated BV-2 microglia by down-regulating proinflammatory mediators corresponding to suppression of NF-κB and MAPK activation. This suggests progesterone may be used as a potential neurotherapeutic to treat inflammatory components of acute brain injury.

Topics

Related research

Therapeutics › Hormonal Agents › Progesterone and Progestins
Beilei Lei, Brian Mace, Hana N Dawson, David S Warner, Daniel T Laskowitz, Michael L James
B Lei, B Mace, H Dawson, Dave Warner, D Warner, Dan Laskowitz, Danny Laskowitz, D Laskowitz, Mike James, M James
PMID 25080336 25080336 DOI 10.1371/journal.pone.0103969 10.1371/journal.pone.0103969 Lei et al. 2014, Lei 2014